Navigation Links
University of California brings researchers together for statewide autism summit
Date:8/13/2014

(SACRAMENTO, Calif.) Bringing together the research prowess of the University of California to address the increase in autism incidence, its public health impacts, and the need to speed the development of treatments for affected individuals and their families, internationally respected scientists from UC campuses at Irvine, Los Angeles, San Diego, San Francisco and Davis will converge at the UC Davis MIND Institute for a daylong summit on innovative translational neurodevelopmental research.

An initiative of the UC Office of the President, the University of California Summit on Translational Research in Autism Spectrum Disorders will be held Thursday, Aug. 14, from 8 a.m. to 5 p.m. at the UC Davis MIND Institute, 2825 50th St., Sacramento. The summit will include a presentation via video conference on "Pressing Issues for a Translational Science of Autism Spectrum Disorder" by Thomas Insel, director of the National Institute of Mental Health (NIMH). Participation in the summit is by invitation only.

"The increase in autism spectrum disorder cases has exceeded the capacity of public and private organizations to provide effective health care, education and treatment to affected families," said Leonard Abbeduto, Vismara-Tsakopoulos Endowed Chair and director of the MIND Institute.

"We must develop new, more effective strategies for treatment and prevention that are informed by a deeper understanding of the etiology, mechanisms and manifestations of the disorder."

Autism spectrum disorder is a lifelong developmental condition with a constellation of symptoms that affect social interactions, behavior and the ability to think, learn and problem solve. The U.S. Centers for Disease Control and Prevention estimates that 1 in 68 children born today will develop the disability, whose incidence has increased by more than 600 percent during the past two decades. More than 350,000 Californians live with autism today.

As one of the world's largest and most prestigious research institutions, the University of California is uniquely positioned to address the mysteries surrounding autism, because of its resources and unrivaled expertise in autism science and health-care delivery. The campuses participating in the summit are those with interdisciplinary autism research programs, integrated health-care systems, and programs that train pediatric health-care professionals. Other UC campuses will participate in follow-up meetings.

The summit also is endorsed by BRAID (Biomedical Research Acceleration, Integration and Development), the unique consortium of the National Institutes of Health (NIH)-funded translational science centers across the UC health centers.

  • UC Irvine Home to the Center for Autism Research and Translation (CART) and the clinical enterprise, The Center for Autism and Neurodevelopmental Disorders, a collaborative of academic, governmental and community institutions in Orange County, Calif.
  • UCLA Home to the Center for Autism Research and Treatment, located in the Semel Institute for Neuroscience and Human Behavior, as well as an NIH Autism Center of Excellence and two NIMH-funded Autism Centers of Excellence.
  • UC San Diego Home to the Autism Discovery Institute, the Beyster Center for Genomics of Neuropsychiatric Diseases, the Center for Brain Development, and the UCSD Autism Center of Excellence.
  • UC San Francisco Home to the UCSF Autism and Neurodevelopment Program.
  • UC Davis - Home to the MIND Institute, a Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)-designated Intellectual and Developmental Disabilites Research Center and an Autism Center of Excellence.

The University of California includes some of the world's leading autism researchers and clinicians in the domains of:

  • Genetic risk factors
  • Environmental risk factors
  • Neurobiology
  • Diagnosis, symptoms, and developmental trajectories
  • Treatment, pharmacology and services
  • Research infrastructure and biorepositories

The summit is the first step toward an ongoing collaboration that will include a coordinated approach to UC autism research, including multi-campus investigations, a system-wide strategic plan, and a series of statewide autism forums that will bring together policymakers, care providers, researchers and the advocacy community, to discuss translating research into improved services for children and adults with autism.

"We are committed to develop a specific action plan for transformative research," said Dan Cooper, chair of the Department of Pediatrics and director of the Institute for Clinical and Translational Science at UC Irvine. "The summit is designed to harness the unique basic science and translational research talent across the UC system in a way that will profoundly benefit children and adults with autism and related disorders."


'/>"/>

Contact: Phyllis Brown
phyllis.brown@ucdmc.ucdavis.edu
916-734-9111
University of California - Davis Health System
Source:Eurekalert

Related biology news :

1. US army award to further University of Tennessee bioenergy research
2. University of Michigan forest preserve joins Smithsonian global network
3. University of Alaska Fairbanks awarded $18.8 million for biomedical research, education
4. University of Minnesota researcher finds cooling effect in warming Arctic lakes
5. Queens University awarded £500,000 to tackle global food fraud
6. Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms
7. University of Maryland Schools of Dentistry and Medicine receive NIH grant
8. University of Houston researcher publishes textbook on tissue engineering
9. York University researchers use bird backpacks to put wood thrushes migration on the map
10. Natural-terrain schoolyards reduce childrens stress, says Colorado University-Boulder study
11. Louisiana Tech University professor presents at International Bioprinting Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/2/2016)... Va. , Feb. 2, 2016   ... award from the U.S. Army Research Office and ... the range and sensitivity of the company,s ... Past Accounting Mission and, more generally, defense-related DNA ... DNA phenotyping capabilities (predicting appearance and ancestry from ...
(Date:2/1/2016)... 2016 Rising sales of consumer ... touchfree intuitive gesture control market size ... of consumer electronics coupled with new technological advancements to ... size through 2020   --> ... technological advancements to drive global touchfree intuitive gesture control ...
Breaking Biology News(10 mins):
(Date:2/3/2016)... Feb. 3, 2016  With the growing need ... that is underway, therapies such as monoclonal antibodies, ... whole host of indications are in high demand. ... the development and production of these therapeutics. However, ... and high costs, novel approaches and novel expression ...
(Date:2/3/2016)... 2016 New Jersey Health Foundation (NJHF) has ... for researchers in New Jersey ... demonstrates exciting potential.   James M. ... New Jersey Health Foundation Research Grant Program ... institutions— Princeton University, Rutgers University, Rowan University and ...
(Date:2/3/2016)... , ... February 03, 2016 , ... ... Linux and Unix visualization solutions today announced the addition of a powerful “Session ... users to see the current state of the remote Linux desktop or other ...
(Date:2/3/2016)... 2016  Today, Symphony Technology Group (STG) announced the ... leading provider of primary research and analytics-based insight for ... , a global information and technology services company serving ... will be integrated into IMS Health to form a ... capabilities. ...
Breaking Biology Technology: